Yong Yu, VP, Clinical Trial Operations at GENELUX Corp (GNLX), sold 32,729 shares at $11.26 ($375K) on 2023-11-20, disclosed to the SEC on 2023-11-21.
Open-market sale of $375k GNLX by VP, Clinical Trial Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.04 | 3,541 | $46K | 12.3% |
| 2 | $11.26 | 14,594 | $164K | 43.8% |
| 3 | $11.26 | 14,594 | $164K | 43.8% |
| Total | $11.45 avg | 32,729 | $375K | 100% |
| Filing → |
| GNLX | SELL | 2026-05-12 | $2K | — | Filing → |
| GNLX | SELL | 2026-03-26 | $2K | — | Filing → |
| GNLX | SELL | 2025-12-11 | $16K | — | Filing → |